ATE332135T1 - Behandlung von brustkarzinomen, astrozytomen, melanomen und verwandten tumoren - Google Patents
Behandlung von brustkarzinomen, astrozytomen, melanomen und verwandten tumorenInfo
- Publication number
- ATE332135T1 ATE332135T1 AT00953647T AT00953647T ATE332135T1 AT E332135 T1 ATE332135 T1 AT E332135T1 AT 00953647 T AT00953647 T AT 00953647T AT 00953647 T AT00953647 T AT 00953647T AT E332135 T1 ATE332135 T1 AT E332135T1
- Authority
- AT
- Austria
- Prior art keywords
- astrocytoma
- melanoma
- related tumors
- drugs
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2000/001760 WO2000044381A1 (en) | 1999-01-28 | 2000-01-24 | Treatment of lymphomas, leukemias, and leiomyomas |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE332135T1 true ATE332135T1 (de) | 2006-07-15 |
Family
ID=21740994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00953647T ATE332135T1 (de) | 2000-01-24 | 2000-07-18 | Behandlung von brustkarzinomen, astrozytomen, melanomen und verwandten tumoren |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1242084B1 (de) |
AT (1) | ATE332135T1 (de) |
AU (1) | AU784523B2 (de) |
CA (1) | CA2388840C (de) |
DE (1) | DE60029246D1 (de) |
WO (1) | WO2001052850A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020081334A (ko) * | 2000-02-21 | 2002-10-26 | 시마르 인코포레이티드 | 간질 치료를 위한 조성물과 방법 |
ATE533486T1 (de) * | 2006-06-15 | 2011-12-15 | Shanghai Genomics Inc | Verwendung von pyridonderivaten zur vorbeugung und behandlung von strahlungsbedingter lungenverletzung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4042699A (en) * | 1972-12-18 | 1977-08-16 | Affiliated Medical Research, Inc. | Method for reducing serum glucose levels |
US5716632A (en) * | 1989-11-22 | 1998-02-10 | Margolin; Solomon B. | Compositions and methods for reparation and prevention of fibrotic lesions |
WO1996027374A1 (en) * | 1995-03-03 | 1996-09-12 | Margolin Solomon B | Treatment of cytokine growth factor caused disorders |
US6114353A (en) * | 1995-03-03 | 2000-09-05 | Margolin; Solomon B. | Compositions and method for treatment of lymphomas, leukemias, and leiomyomas |
US5962478A (en) * | 1995-09-19 | 1999-10-05 | Margolin; Solomon B. | Inhibition of tumor necrosis factor α |
-
2000
- 2000-07-18 EP EP00953647A patent/EP1242084B1/de not_active Expired - Lifetime
- 2000-07-18 AT AT00953647T patent/ATE332135T1/de not_active IP Right Cessation
- 2000-07-18 DE DE60029246T patent/DE60029246D1/de not_active Expired - Fee Related
- 2000-07-18 WO PCT/US2000/019518 patent/WO2001052850A1/en active IP Right Grant
- 2000-07-18 AU AU66061/00A patent/AU784523B2/en not_active Ceased
- 2000-07-18 CA CA2388840A patent/CA2388840C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1242084B1 (de) | 2006-07-05 |
EP1242084A4 (de) | 2004-01-14 |
WO2001052850A1 (en) | 2001-07-26 |
EP1242084A1 (de) | 2002-09-25 |
DE60029246D1 (de) | 2006-08-17 |
CA2388840C (en) | 2011-09-13 |
AU6606100A (en) | 2001-07-31 |
AU784523B2 (en) | 2006-04-27 |
CA2388840A1 (en) | 2001-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY131911A (en) | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives | |
DE69925256D1 (de) | Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen | |
CY1105225T1 (el) | Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας | |
DE60314633D1 (de) | Substituierte 1,3-diphenylprop-2-en-1-on derivate, deren herstellung und anwendungen | |
CY1106467T1 (el) | Ελεγχομενη συνθεση ζιπρασιδονης | |
ECSP045139A (es) | DERIVADOS DE ACETILENO QUE TIENEN ACTIVIDAD ANTAGONISTICA DE MGluR5 | |
BR0307058A (pt) | N-óxidos de derivados de n-fenil-2-pirimidina-amina | |
MY138966A (en) | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | |
ATE236147T1 (de) | Derivate von flavonen, xanthonen und kumarinen | |
WO2003005999A8 (en) | Methods of treating cytokine mediated diseases | |
MY139102A (en) | Substituted n-aryl heterocycles, process for their preparation and their use as medicaments | |
GEP20053600B (en) | 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors | |
BG108225A (en) | Thiohydantoins and use thereof for treating diabetes | |
TR200200883T2 (tr) | 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları | |
MX2022013051A (es) | Agentes quimioterapéuticos de éteres macrocíclicos heteroaromáticos. | |
DK1044197T3 (da) | Piperidinylsubstituerede pyridylalkan-, -alken- og -alkyncarboxamider som cytostatiske midler og immunosuppressive midler | |
YU21401A (sh) | Tetrahidropiridoetri | |
DK1414813T3 (da) | Antimalariamidler baseret på 1,3,4-trioxolan | |
NO20001483L (no) | Nye NPY-agonister | |
DE60014136D1 (de) | Sapogenin derivate zur behandlung von kognitiven störungen | |
IS6319A (is) | Indólýl-3-glýoxý sýru afleiður sem innihalda gagnlega meðferðarlega eiginleika | |
BR0017157A (pt) | Derivados de 6-hidroxi-indazol para o tratamento de glaucoma | |
CY1106713T1 (el) | Συνδυασμενη θεραπεια εναντιον καρκινωματων η οποια περιλαμβανει παραγωγα υποκαταστημενης ακρυλοϋλ δισταμυσινης και αλκυλιωτικους παραγοντες | |
ATE479657T1 (de) | N-(aryl)-2-arylethensulfonamide und ihre therapeutischen anwendungen | |
IL152097A0 (en) | Use of pyrazole derivatives for treating infertility |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |